Toxicology – High-Risk Low-Dose Pediatric Poisoning

Definition

High-risk low-dose pediatric poisoning refers to accidental exposure to medications or chemicals capable of producing severe or potentially fatal toxicity after ingestion of a relatively small amount by a young child.

Young children are particularly susceptible because their low body weight means that even a single adult-strength tablet or small volume of a concentrated product may represent a substantial weight-adjusted toxic exposure.

Although most accidental childhood ingestions cause minimal toxicity, certain substances have:

• A narrow therapeutic index
• High intrinsic toxicity
• Potent cardiovascular or neurologic effects
• Delayed toxicity
• Long duration of action

These exposures require careful assessment even when the child is initially asymptomatic.

Major High-Risk Drug Classes

Sulfonylureas

Sulfonylureas are important causes of severe pediatric hypoglycemia.

Examples include:

• Glyburide/glibenclamide
• Glipizide
• Glimepiride
• Gliclazide

A relatively small exposure may stimulate excessive pancreatic insulin release.

Clinical manifestations include:

• Sweating
• Pallor
• Irritability
• Lethargy
• Confusion
• Seizures
• Coma

Hypoglycemia may be delayed, prolonged, or recurrent.

Treatment includes correction of hypoglycemia, with octreotide used in clinically significant sulfonylurea poisoning to suppress further insulin secretion.

Opioids

Young children are highly susceptible to opioid-induced respiratory depression.

Important agents include:

• Methadone
• Codeine
• Hydrocodone
• Other potent or long-acting opioids

Typical findings include:

• CNS depression
• Miosis
• Bradypnea
• Hypoventilation
• Bradycardia
• Hypotension

The most dangerous manifestation is respiratory failure.

Naloxone is indicated when clinically significant opioid-induced respiratory depression is present.

The therapeutic goal is restoration of adequate ventilation rather than complete awakening.

Clonidine and Imidazoline Agents

Clonidine and related imidazolines may cause substantial toxicity following a small pediatric exposure.

Clinical findings include:

• Somnolence
• Miosis
• Bradycardia
• Hypotension
• Respiratory depression

The syndrome may closely resemble opioid toxicity.

An early transient hypertensive phase can occasionally occur.

Tricyclic Antidepressants

Tricyclic antidepressants can produce rapidly progressive neurologic and cardiovascular toxicity.

Examples include:

• Amitriptyline
• Imipramine
• Desipramine

Clinical manifestations include:

• Anticholinergic findings
• Altered mental status
• Seizures
• Hypotension
• QRS widening
• Ventricular dysrhythmias

Severe cardiotoxicity primarily results from fast sodium-channel blockade.

Significant sodium-channel cardiotoxicity is treated with sodium bicarbonate.

Calcium Channel Blockers

Calcium channel blockers can cause severe cardiovascular poisoning.

Important agents include:

• Verapamil
• Diltiazem
• Nifedipine

Manifestations include:

• Bradycardia
• AV conduction abnormalities
• Myocardial depression
• Peripheral vasodilation
• Hypotension
• Cardiogenic or mixed shock

Hyperglycemia is an important clue to significant calcium channel blocker toxicity.

Extended-release preparations may produce delayed and prolonged toxicity.

Severe poisoning may require:

• Calcium
• Vasopressors
• Hyperinsulinemic euglycemia therapy
• Advanced circulatory support

Beta-Adrenergic Blockers

Beta-blocker poisoning may produce:

• Bradycardia
• Hypotension
• AV block
• Reduced myocardial contractility
• CNS depression

Some beta-blockers may additionally cause:

• Seizures
• QRS widening
• Ventricular dysrhythmias

Hypoglycemia can occur, particularly in young children.

Severe cases may require vasopressors and hyperinsulinemic euglycemia therapy, with other therapies selected according to the specific beta-blocker and clinical syndrome.

Antimalarial Agents

Certain antimalarial medications can cause profound cardiovascular toxicity following relatively small pediatric exposures.

Important examples include:

• Chloroquine
• Hydroxychloroquine
• Quinine

Severe toxicity may cause:

• Hypotension
• QRS widening
• QT abnormalities
• Ventricular dysrhythmias
• Seizures
• Hypokalemia
• Cardiovascular collapse

These exposures require urgent medical assessment.

Theophylline

Theophylline has a narrow therapeutic index.

Toxicity may produce:

• Nausea and vomiting
• Tremor
• Agitation
• Tachycardia
• Hypokalemia
• Hyperglycemia
• Seizures
• Ventricular dysrhythmias

Extended-release preparations can cause delayed and prolonged toxicity.

Diphenoxylate

Diphenoxylate-containing antidiarrheal medications can produce opioid-like toxicity in children.

Manifestations include:

• CNS depression
• Miosis
• Respiratory depression
• Bradycardia

Toxicity may be delayed or prolonged.

Naloxone may reverse clinically significant opioid effects.

High-Risk Small-Volume Chemical Exposures

Methanol

Methanol is metabolized to toxic metabolites that can produce:

• High-anion-gap metabolic acidosis
• Visual impairment
• CNS depression
• Seizures
• Coma

Severe poisoning can cause permanent visual and neurologic injury.

Fomepizole inhibits toxic metabolite formation.

Severe poisoning may require hemodialysis.

Ethylene Glycol

Ethylene glycol metabolism produces toxic organic acids.

Clinical manifestations may include:

• CNS depression
• High-anion-gap metabolic acidosis
• Hypocalcemia
• Acute kidney injury

Treatment includes fomepizole, supportive care, and hemodialysis in severe cases.

Methyl Salicylate

Methyl salicylate, commonly found in oil of wintergreen, is a highly concentrated salicylate preparation.

Significant poisoning can produce:

• Vomiting
• Tachypnea
• Diaphoresis
• Tinnitus
• Respiratory alkalosis
• High-anion-gap metabolic acidosis
• Hyperthermia
• Altered mental status

Serial salicylate concentrations and acid-base assessment are important.

Severe toxicity may require urinary alkalinization and hemodialysis.

Camphor

Camphor can produce rapid CNS toxicity.

Manifestations include:

• Nausea
• Vomiting
• Agitation
• Confusion
• Seizures

Neurologic deterioration may occur rapidly after exposure.

Hydrofluoric Acid and Fluoride Compounds

Concentrated fluoride exposure can produce both local tissue injury and severe systemic electrolyte abnormalities.

Potential complications include:

• Hypocalcemia
• Hypomagnesemia
• Hyperkalemia
• QT prolongation
• Ventricular dysrhythmias
• Cardiovascular collapse

These exposures require urgent assessment and correction of electrolyte abnormalities.

Corrosive Substances

Concentrated acids and alkalis may cause severe injury even after relatively small exposures.

Potential complications include:

• Oropharyngeal injury
• Airway edema
• Esophageal burns
• Gastric injury
• Perforation
• Later stricture formation

The absence of oral burns does not exclude significant esophageal injury.

Do not induce vomiting or attempt chemical neutralization.

Activated charcoal generally has no role in corrosive ingestion.

Organophosphate Insecticides

Concentrated organophosphate exposure causes excessive acetylcholine accumulation.

Muscarinic manifestations include:

• Miosis
• Salivation
• Lacrimation
• Bronchorrhea
• Bronchospasm
• Vomiting
• Diarrhea
• Bradycardia

Nicotinic manifestations include:

• Fasciculations
• Weakness
• Paralysis

Severe poisoning can cause respiratory failure.

Treatment includes atropine, supportive respiratory care, and pralidoxime for significant organophosphate poisoning.

Paraquat

Paraquat poisoning can cause severe multisystem toxicity.

Early manifestations may include:

• Oral and gastrointestinal corrosive injury
• Nausea
• Vomiting
• Abdominal pain

Severe poisoning may progress to:

• Acute kidney injury
• Hepatic injury
• Progressive pulmonary toxicity
• Multiorgan failure

Suspected ingestion requires immediate specialist toxicology assessment.

Concentrated Hydrogen Peroxide

Highly concentrated hydrogen peroxide can release large quantities of oxygen after contact with tissues.

Potential complications include:

• Gastrointestinal irritation
• Gastric distension
• Mucosal injury
• Gas embolism
• Neurologic complications
• Cardiovascular instability

Toxicity depends strongly on the concentration and amount of product involved.

Amatoxin-Containing Mushrooms

Certain mushrooms, particularly Amanita phalloides and related amatoxin-containing species, can cause severe hepatic toxicity.

Typical progression:

Latent asymptomatic phase → severe gastroenteritis → temporary clinical improvement → hepatic failure

The apparent improvement after gastrointestinal symptoms can be misleading.

Severe cases may progress to:

• Coagulopathy
• Hypoglycemia
• Encephalopathy
• Multiorgan failure

Lead-Containing Foreign Bodies

Ingested lead-containing objects can cause significant toxicity when retained within the gastrointestinal tract.

Potential consequences include:

• Elevated blood lead concentrations
• Abdominal symptoms
• Neurologic toxicity
• Hematologic abnormalities

Management depends on the location and retention of the object, blood lead concentration, and clinical condition.

Major Toxicologic Syndromes

Respiratory Depression

Important causes:

• Opioids
• Clonidine/imidazolines
• Diphenoxylate

Clinical priority:

Assess ventilation and airway protection.

Hypoglycemia

Important cause:

• Sulfonylureas

Because hypoglycemia may recur, serial glucose monitoring is essential.

Cardiovascular Toxicity

Important causes:

• Tricyclic antidepressants
• Calcium channel blockers
• Beta-blockers
• Chloroquine/hydroxychloroquine

Possible manifestations:

• Bradycardia
• Conduction abnormalities
• QRS widening
• Dysrhythmias
• Hypotension
• Shock

Seizures

Important toxicologic causes include:

• Tricyclic antidepressants
• Theophylline
• Camphor
• Chloroquine
• Stimulants

Seizures may contribute to:

• Hyperthermia
• Lactic acidosis
• Rhabdomyolysis
• Hypoxia

Delayed Organ Toxicity

Important causes include:

• Methanol
• Ethylene glycol
• Amatoxin-containing mushrooms
• Paraquat
• Extended-release medications

Therefore, the absence of early symptoms does not necessarily indicate a benign exposure.

Evaluation of the Initially Asymptomatic Child

A normal initial examination does not reliably exclude serious poisoning.

Delayed toxicity can result from:

• Extended-release formulations
• Delayed gastrointestinal absorption
• Formation of toxic metabolites
• Long drug half-lives
• Recurrent hypoglycemia
• Delayed hepatic, renal, or pulmonary injury

Observation should therefore be determined by the specific toxicant and formulation, rather than using a universal observation period.

Exposure History

Important information includes:

• Exact medication or chemical
• Active ingredient
• Formulation
• Concentration or tablet strength
• Immediate-release versus extended-release preparation
• Child’s weight
• Maximum possible amount involved
• Time of exposure
• Presence of coingestants
• Current symptoms

Whenever possible, the original medication or product container should be identified.

Initial Clinical Assessment

Evaluate:

• Airway patency
• Respiratory rate and effort
• Ventilation
• Oxygenation
• Mental status
• Heart rate
• Blood pressure
• Temperature
• Pupils
• Neuromuscular findings

A bedside blood glucose should be obtained early in unexplained altered mental status, seizures, or suspected hypoglycemic-agent exposure.

ECG Assessment

ECG monitoring is particularly important with suspected:

• Tricyclic antidepressants
• Sodium-channel blockers
• Beta-blockers
• Calcium channel blockers
• Chloroquine/hydroxychloroquine
• Other cardiotoxic medications

Important abnormalities include:

• Bradycardia
• AV block
• QRS widening
• QT prolongation
• Ventricular dysrhythmias

Laboratory Evaluation

Testing should be directed by the suspected exposure.

Possible studies include:

• Glucose
• Electrolytes
• Renal function
• Blood gas
• Lactate
• Acetaminophen concentration when indicated
• Salicylate concentration
• Toxic alcohol evaluation
• Drug-specific concentrations when clinically useful

Routine broad toxicology screening should not replace a careful exposure history and targeted testing.

Management Principles

The general approach is:

Identify exposure → assess ABCs → recognize expected toxidrome → anticipate delayed toxicity → initiate specific/supportive treatment → monitor appropriately

Potentially dangerous pediatric ingestions can deteriorate rapidly despite an initially normal examination.

Gastrointestinal Decontamination

Induced vomiting is not recommended.

Routine gastric lavage is generally not indicated.

Activated charcoal may be considered for selected potentially serious recent ingestions when:

• The substance is effectively adsorbed,
• A meaningful clinical benefit is expected, and
• The airway is adequately protected.

Decontamination should never delay stabilization or administration of an urgently required antidote.

Observation and Disposition

Observation duration should be toxicant-specific.

Prolonged monitoring may be required for:

• Extended-release medications
• Sulfonylureas
• Long-acting opioids
• Calcium channel blockers
• Toxic alcohols
• Substances causing delayed organ injury

Symptomatic patients or children with potentially serious exposures generally require monitored medical evaluation.

Key Points

• High-risk low-dose pediatric poisoning is a more clinically descriptive term for the traditional “one pill can kill” concept.
• It describes medications or chemicals capable of producing severe toxicity from relatively small pediatric exposures.
• Young children are particularly vulnerable because a small absolute amount may represent a large weight-adjusted dose.
• Important high-risk medications include sulfonylureas, opioids, clonidine, TCAs, calcium channel blockers, beta-blockers, antimalarials, and theophylline.
• Sulfonylureas can cause delayed and recurrent hypoglycemia.
• Opioids and clonidine can cause CNS and respiratory depression.
• TCAs and other cardiotoxic medications can cause seizures, conduction abnormalities, dysrhythmias, and shock.
• Small-volume chemical exposures can also be dangerous, particularly toxic alcohols, concentrated salicylates, corrosives, hydrofluoric acid, paraquat, and concentrated hydrogen peroxide.
• Some dangerous poisonings have an initially asymptomatic period.
• Obtain the exact product, formulation, strength, timing, maximum possible exposure, and child’s weight.
• Observation and treatment should be based on the specific toxicant and its pharmacokinetics, rather than a universal “one-pill” rule.